Paraprotein levels in assessing effectiveness of polychemotherapy plus selective plasma exchange for multiple myeloma patients.

被引：0
|
作者：
Lysenko, Irina B.
Guskova, Nailya
Kit, Oleg Ivanovich
Ushakova, Natalya Dmitrievna
Golomeeva, Nadezhda
Zuderman, Natalia
Guskova, Ekaterina
Nozdricheva, Anastasia
Abakumova, Svetlana V.
Donskaya, Aliya K.
Gusareva, Marina A.
Avanesova, Kristina
Torpudzhyan, Izabella
Tselishcheva, Irina V.
Zakharchenko, Viktoria
Belgova, Svetlana V.
Gornostaeva, Ekaterina
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e19511
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19511
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Serum levels of OPG and MIP-1α in untreated multiple myeloma patients.: Correlations with staging, survival and bone disease.
    Papadogiannis, A
    Kyrtsonis, MC
    Vassilakopoulos, TP
    Tzenou, T
    Antoniadis, AG
    Kalpadakis, C
    Sachanas, S
    Dimopoulou, MN
    Siakantaris, MP
    Kokoris, SI
    Dimitriadou, EM
    Angelopoulou, MK
    Plata, E
    Tsaftaridis, P
    Pangalis, G
    BLOOD, 2005, 106 (11) : 350B - 350B
  • [32] Phase I/II trial assessing bendamustine plus bortezomib combination therapy for the treatment of patients with relapsed or refractory multiple myeloma
    Berenson, James R.
    Yellin, Ori
    Bessudo, Alberto
    Boccia, Ralph V.
    Noga, Stephen J.
    Gravenor, Donald S.
    Patel-Donnelly, Dipti
    Siegel, Robert S.
    Kewalramani, Tarun
    Gorak, Edward J.
    Nassir, Youram
    Swift, Regina A.
    Mayo, Debra
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 160 (03) : 321 - 330
  • [33] Comparison between DNA ploidy analysis and immunophenotyping for evaluation of treatment-induced plasma cell changes in multiple myeloma patients.
    Mateo, G
    Almeida, J
    Vidriales, B
    Caballero, MD
    Blade, J
    Palomera, L
    Moro, MJ
    Ortega, F
    Hernández, J
    Orfao, A
    San Miguel, JF
    BLOOD, 2001, 98 (11) : 157A - 157A
  • [34] Increased Levels of Circulating Plasma Cells in Patients with Newly Diagnosed Multiple Myeloma Are Independently Associated with Poor Prognosis
    Kostopoulos, Ioannis, V
    Malandrakis, Panagiotis
    Ntanasis-Stathopoulos, Ioannis
    Roussakis, Pantelis
    Papaiakovou, Evangelos Eleutherakis
    Panteli, Chrysanthi
    Angelis, Nikolaos
    Kanellias, Nikolaos
    Orologas-Stavrou, Nikolaos
    Theodorakakou, Foteini
    Fotiou, Despina
    Migkou, Magdalini
    Gavriatopoulou, Maria
    Kastritis, Efstathios
    Tsitsilonis, Ourania E.
    Dimopoulos, Meletios-Athanasios
    Terpos, Evangelos
    BLOOD, 2022, 140 : 1564 - 1565
  • [35] Tumor angiogenesis is associated with plasma levels of stromal-derived factor-1α in patients with multiple myeloma
    Martin, Sally K.
    Dewar, Andrea L.
    Farrugia, Amanda N.
    Horvath, Noemi
    Gronthos, Stan
    To, L. Bik
    Zannettino, Andrew C. W.
    CLINICAL CANCER RESEARCH, 2006, 12 (23) : 6973 - 6977
  • [36] Reduced IL-33 plasma levels in multiple myeloma patients are associated with more advanced stage of disease
    Musolino, Caterina
    Allegra, Alessandro
    Profita, Mirella
    Alonci, Andrea
    Saitta, Salvatore
    Russo, Sabina
    Bonanno, Anna
    Innao, Vanessa
    Gangemi, Sebastiano
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 160 (05) : 709 - 710
  • [37] Plasma Levels of Monocyte Chemotactic Protein-1 Are Associated with Clinical Features and Angiogenesis in Patients with Multiple Myeloma
    Valkovic, Toni
    Babarovic, Emina
    Lucin, Ksenija
    Stifter, Sanja
    Aralica, Merica
    Seili-Bekafigo, Irena
    Duletic-Nacinovic, Antica
    Jonjic, Nives
    BIOMED RESEARCH INTERNATIONAL, 2016, 2016
  • [38] Quantification of bone-marrow plasma cell levels using various International Myeloma Working Group response criteria in patients with multiple myeloma
    Kentaro Narita
    Hiroki Kobayashi
    Yoshiaki Abe
    Hiroaki Kitadate
    Masami Takeuchi
    Kosei Matsue
    International Journal of Hematology, 2018, 108 : 371 - 374
  • [39] Quantification of bone-marrow plasma cell levels using various International Myeloma Working Group response criteria in patients with multiple myeloma
    Narita, Kentaro
    Kobayashi, Hiroki
    Abe, Yoshiaki
    Kitadate, Hiroaki
    Takeuchi, Masami
    Matsue, Kosei
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2018, 108 (04) : 371 - 374
  • [40] HIGHER LEVELS OF GENOMIC COMPLEXITY CORRELATES WITH AN ADVANCED PLASMA CELL DIFFERENTIATION STATUS IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
    Termini, R.
    Martello, M.
    Santacroce, B.
    Solli, V.
    Borsi, E.
    Benni, C.
    Poletti, A.
    Pantani, L.
    Rocchi, S.
    Mancuso, K.
    Zamagni, E.
    Tacchetti, P.
    Ulbar, F.
    Arpinati, M.
    Chirumbolo, G.
    Testoni, N.
    Marzocchi, G.
    Cavo, M.
    Terragna, C.
    HAEMATOLOGICA, 2018, 103 : S52 - S53
12345